Literature DB >> 17440728

Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis.

Adel M Al-Awadhi1, Eman A Hasan, Prem N Sharma, M Zafaryab Haider, Khaled Al-Saeid.   

Abstract

To investigate the frequency of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism genotypes in adults with psoriatic arthritis (PsA), a heterogeneous chronic disease with autoimmune pathology. ACE gene I/D polymorphism influences the plasma and tissue levels of ACE and has an involvement in inflammatory mechanism. The frequency of ACE gene I/D polymorphism genotypes was determined in 51 adults with PsA from Kuwait, and compared to that in 100 ethnically matched healthy controls using polymerase chain reaction. The distribution of ACE I/D polymorphism and allele frequencies in PsA patients were not significantly different from controls (P > 0.05). Further analyses of PsA patients showed that ACE I/D gene polymorphism was not associated with family history, clinical manifestations, and disease severity. However, the frequency of II genotype was significantly higher in patients with late disease onset than in those with early onset (25 vs. 3%; P = 0.04). No difference was found between the distribution of the ACE genotype in PsA patients and the general population in Kuwait. However, the presence of II genotype may confer susceptibility to the development of late onset PsA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440728     DOI: 10.1007/s00296-007-0349-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

Review 1.  Genetic factors in psoriatic arthritis.

Authors:  Eleanor Korendowych; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

2.  Immunoglobulin heavy chain gene polymorphisms in Italian patients with psoriasis and psoriatic arthritis.

Authors:  L I Sakkas; A Marchesoni; L A Kerr; R Ranza; B Colombo; K I Welsh; G S Panayi
Journal:  Br J Rheumatol       Date:  1991-12

3.  Release of angiotensin I-converting enzyme by endothelial cells in vitro.

Authors:  J P Noveral; S N Mueller; E M Levine
Journal:  J Cell Physiol       Date:  1987-04       Impact factor: 6.384

4.  Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition.

Authors:  M Goto; M Fujisawa; A Yamada; T Okabe; F Takaku; M Sasano; K Nishioka
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

5.  Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with psoriasis.

Authors:  M Ozkur; Z Erbagci; M Nacak; A A Tuncel; B Alasehirli; A S Aynacioglu
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

6.  Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis.

Authors:  T Höhler; S Grossmann; B Stradmann-Bellinghausen; W Kaluza; E Reuss; K de Vlam; E Veys; E Märker-Hermann
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

7.  Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.

Authors:  N J McHugh; C Balachrishnan; S M Jones
Journal:  Rheumatology (Oxford)       Date:  2003-03-14       Impact factor: 7.580

8.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

9.  Production of angiotensin converting enzyme by rheumatoid synovial membrane.

Authors:  D Veale; G Yanni; B Bresnihan; O FitzGerald
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

10.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

View more
  6 in total

Review 1.  The perspective on psoriatic arthritis in Asia.

Authors:  Ying-Ying Leung; Lai-Shan Tam; Edmund K Li
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

2.  Association of GSTM1, GSTT1, GSTP1-ILE105VAL and ACE I/D polymorphisms with ankylosing spondylitis.

Authors:  Esra Erkol İnal; Orhan Görükmez; Selma Eroğlu; Özlem Görükmez; Özlem Solak; Ali Topak; Tahsin Yakut
Journal:  Rheumatol Int       Date:  2015-07-18       Impact factor: 2.631

3.  The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease.

Authors:  Esther Kuperus; Jan C van der Meijden; Stijn L M In 't Groen; Marian A Kroos; Marianne Hoogeveen-Westerveld; Dimitris Rizopoulos; Monica Yasmin Nino Martinez; Michelle E Kruijshaar; Pieter A van Doorn; Nadine A M E van der Beek; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

4.  Angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to psoriasis: a systematic review and meta-analysis.

Authors:  Mazaher Ramezani; Elisa Zavattaro; Masoud Sadeghi
Journal:  BMC Med Genet       Date:  2020-01-08       Impact factor: 2.103

5.  Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Authors:  Boglárka Soós; Miklós Fagyas; Ágnes Horváth; Edit Végh; Anita Pusztai; Monika Czókolyová; Alexandra Csongrádi; Attila Hamar; Zsófia Pethő; Nóra Bodnár; György Kerekes; Katalin Hodosi; Éva Szekanecz; Szilvia Szamosi; Sándor Szántó; Gabriella Szűcs; Zoltán Papp; Zoltán Szekanecz
Journal:  Front Med (Lausanne)       Date:  2022-01-27

Review 6.  The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics.

Authors:  Dan-In Jang; A-Hyeon Lee; Hye-Yoon Shin; Hyo-Ryeong Song; Jong-Hwi Park; Tae-Bong Kang; Sang-Ryong Lee; Seung-Hoon Yang
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.